These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation. Nguyen LL J Vasc Surg; 2007 Jun; 45 Suppl A(Suppl A):A149-57. PubMed ID: 17544036 [TBL] [Abstract][Full Text] [Related]
4. Determining the Minimally Important Difference for the VascuQol Sumscore and Its Domains in Patients with Intermittent Claudication. Conijn AP; Bipat S; Reekers JA; Koelemay MJ Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):550-6. PubMed ID: 26837479 [TBL] [Abstract][Full Text] [Related]
5. Cost determinants of percutaneous and surgical interventions for treatment of intermittent claudication from the perspective of the hospital. Janne d'Othée B; Morris MF; Powell RJ; Bettmann MA Cardiovasc Intervent Radiol; 2008; 31(1):56-65. PubMed ID: 17973158 [TBL] [Abstract][Full Text] [Related]
6. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. Kalbaugh CA; Taylor SM; Blackhurst DW; Dellinger MB; Trent EA; Youkey JR J Vasc Surg; 2006 Aug; 44(2):296-302; discussion 302-3. PubMed ID: 16814976 [TBL] [Abstract][Full Text] [Related]
7. Balloon angioplasty or nitinol stents for peripheral-artery disease. Golledge J; Norman P N Engl J Med; 2006 Aug; 355(5):522; author reply 523-4. PubMed ID: 16888843 [No Abstract] [Full Text] [Related]
8. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease. Treesak C; Kasemsup V; Treat-Jacobson D; Nyman JA; Hirsch AT Vasc Med; 2004 Nov; 9(4):279-85. PubMed ID: 15678620 [TBL] [Abstract][Full Text] [Related]
9. Discrepancies between patient-reported outcomes and clinician-reported outcomes in chronic venous disease, irritable bowel syndrome, and peripheral arterial occlusive disease. Chassany O; Le-Jeunne P; Duracinsky M; Schwalm MS; Mathieu M Value Health; 2006; 9(1):39-46. PubMed ID: 16441523 [TBL] [Abstract][Full Text] [Related]
11. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Nylaende M; Abdelnoor M; Stranden E; Morken B; Sandbaek G; Risum Ø; Jørgensen JJ; Lindahl AK; Arnesen H; Seljeflot I; Kroese AJ Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):3-12. PubMed ID: 17055756 [TBL] [Abstract][Full Text] [Related]
12. The Australian Vascular Quality of Life Index (AUSVIQUOL): an improved clinical quality of life tool for peripheral vascular disease. Smith MJ; Borchard KL; Hinton E; Scott AR Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):199-205. PubMed ID: 17433884 [TBL] [Abstract][Full Text] [Related]
13. Risk attitudes to treatment among patients with severe intermittent claudication. Letterstål A; Forsberg C; Olofsson P; Wahlberg E J Vasc Surg; 2008 May; 47(5):988-94. PubMed ID: 18455642 [TBL] [Abstract][Full Text] [Related]
14. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Regensteiner JG; Hiatt WR; Coll JR; Criqui MH; Treat-Jacobson D; McDermott MM; Hirsch AT Vasc Med; 2008 Feb; 13(1):15-24. PubMed ID: 18372434 [TBL] [Abstract][Full Text] [Related]
15. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. Hunink MG; Wong JB; Donaldson MC; Meyerovitz MF; de Vries J; Harrington DP JAMA; 1995 Jul; 274(2):165-71. PubMed ID: 7596006 [TBL] [Abstract][Full Text] [Related]
17. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. Mazari FA; Khan JA; Carradice D; Samuel N; Gohil R; McCollum PT; Chetter IC Br J Surg; 2013 Aug; 100(9):1172-9. PubMed ID: 23842831 [TBL] [Abstract][Full Text] [Related]
18. Lower extremity angioplasty: impact of practitioner specialty and volume on practice patterns and healthcare resource utilization. Vogel TR; Dombrovskiy VY; Carson JL; Haser PB; Graham AM J Vasc Surg; 2009 Dec; 50(6):1320-4; discussion 1324-5. PubMed ID: 19837538 [TBL] [Abstract][Full Text] [Related]
19. The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Hobbs SD; Bradbury AW J Vasc Surg; 2006 Aug; 44(2):432-3. PubMed ID: 16890883 [No Abstract] [Full Text] [Related]
20. Type-D personality and ankle brachial index as predictors of impaired quality of life and depressive symptoms in peripheral arterial disease. Aquarius AE; Denollet J; Hamming JF; Van Berge Henegouwen DP; De Vries J Arch Surg; 2007 Jul; 142(7):662-7. PubMed ID: 17638805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]